From: A meta-analysis of the prevalence of Toxoplasma gondii in animals and humans in Ethiopia
Author | Year of study | Location | Host | Method | Number | Positive (%) |
---|---|---|---|---|---|---|
Zewdu et al. [27] | 2010–2011 | CE | Goat | ELISA | 927 | 183 (19.74) |
Gebremedhin et al. [28] | 2010–2011 | CE | Sheep | ELISA | 1030 | 357 (34.66) |
Teshale [29] | 2005–2006 | CSE | Sheep, goat | MDAT | 641 | 480 (74.88) |
Demissie and Tilahun [30] | 2000–2001 | CE | Sheep, goat | MDAT | 468 | 159 (33.97) |
Negash et al. [31] | 1999–2000 | CE | Sheep, goat | MDAT/ELISA | 174 | 75 (43.10) |
Gebremedhin and Gizaw [32] | 2013–2014 | SE | Sheep, goat | ELISA | 184 | 48 (26.09) |
Gebremedhin et al. [33] | 2011–2012 | CE | Sheep, goat | DAT | 628 | 111 (17.68) |
Gebremedhin et al. [34] | 2012–2013 | CE | Camel | MAT | 385 | 187 (48.57) |
Tilahun et al. [35] | 2012 | CE | Chicken | MAT | 125 | 48 (38.40) |
Gebremedhin et al. [36] | 2012–2013 | CE | Chicken | MAT | 601 | 183 (30.45) |
Gebremedhin et al. [37] | 2014 | CE | Pig | DAT | 402 | 129 (32.09) |
Dubey [38] | 2011 | CE | Cat | MAT | 36 | 33 (91.67) |
Tiao [39] | 2012 | CE | Cat | MAT | 48 | 41 (85.42) |
Negash et al. [31] | 1999–2000 | CE | Cat | Coprology | 40 | 5 (12.5) |
Dubey [38] | 2011 | CE | Cat | Coprology | 36 | 8 (22.22) |
Mellbin and Vahlquist [40] | nr | WCSE | human | SFT | 267 | 102 (38.20) |
De Roever–Bonnet [41] | nr | CE | human | SFT | 99 | 47 (47.47) |
Guebre Xabier et al. [42] | 1990 | CSE | human | ELISA | 919 | 673 (73.23) |
Eshete et al. [43] | nr | CE | human | ELISA | 94 | 19 (20.21) |
Woldemichael et al.[44] | 1995–1996 | CE | human | SFT/LAT | 340 | 268 (78.82) |
Negash et al. [45] | 1999–2000 | CE | human | MDAT | 65 | 39 (60.00) |
Yimer et al. [46] | nr | CE | human | ELISA | 279 | 270 (96.77) |
Shibre et al. [47]a | 2005 | CE | human | ELISA | 90 | 80 (88.89) |
Shimelis et al. [48] | 2007 | CE | human | ELISA | 330 | 297 (90.00) |
Tedla et al. [49]a | 2009 | CE | human | ELISA | 456 | 434 (95.18) |
Zemene et al. [50] | 2011 | SE | human | ELISA | 201 | 163 (81.09) |
Gebremedhin et al. [51] | 2010–2011 | CE | human | ELISA | 425 | 346 (81.41) |
Aleme et al. [52] | 2011–2012 | CE | human | ELISA | 150 | 141 (94.00) |
Walle et al. [53] | nr | NE | human | ELISA | 204 | 161 (78.92) |
Muluye et al. [54] | 2012–2013 | NE | human | LAT | 170 | 130 (76.47) |
Tadesse et al. [55] | 2012 | NE | human | LAT | 422 | 171 (40.52) |
Endris et al. [56] | 2010–2011 | NE | human | LAT | 385 | 341 (88.57) |
Zeweld et al. [57] | 2012–2013 | NE | human | ELISA | 651 | 51 (7.83) |
Yohannes et al. [58] | 2013 | SE | human | ELISA | 170 | 150 (88.24) |